Tesla is un-canceling its plan to build a smaller, cheaper EV: report

Reuters reports Tesla is reviving plans for an all-new, lower-cost EV (formerly the canceled $25k 'Model 2') that would be built first in China and later brought to the US and Europe. Tesla's Q1 deliveries were up year-over-year but down 14% sequentially, and the company is facing headwinds from the loss of the EV tax credit and setbacks in Full Self-Driving (FSD) — real-time FSD miles sit at 9.1B versus a cited 10B-mile validation target. A cheaper model could provide a material sales boost but would mark a strategic reversal from Musk's driverless-first stance and raises questions about supply-chain, autonomy integration, and near-term execution.

Analysis

This potential China-first, low-cost SUV is a strategic admission that the FSD/robotaxi cash flow is farther out than management projected — the company is re-introducing a classic volume play to restore utilization and near-term revenue. To hit a sub-$30k ASP while preserving corporate margins Tesla will need 20-30% unit COGS reduction vs current refreshed-model builds or a 2x+ unit volume uplift; failure on either axis forces gross-margin compression that equity markets will punish quickly.

The supply-chain winners are likely Chinese cell/LFP makers, local stampings and e-drive suppliers that enable cost-downs via localization; Western Tier-1s tied to higher-cost platforms face margin leakage and order deferral. Secondary effects include accelerated price competition in China that forces legacy OEMs to accelerate EV cost programs, and an elevated chance of trade/tax friction when importing China-built cars into US/EU markets — domestic-content rules could add 12–24 months and incremental CAPEX to certify variants.

Execution risk is the material one: dual-specifying for both human driving and a pathway to driverless increases unit engineering/parts cost by an estimated $1k–$3k, and regulatory or FSD-safety milestones (the next billion miles) are binary near-term catalysts. Timing: supplier RFPs/tooling in 3–9 months, China volume ramp 12–24 months, US/EU introduction 24–36 months.

From a market-structure view, the clean tactical play is to monetize near-term margin downside while keeping optionality on a longer-term volume upside — the option surface (elevated near-term implied vol, cheaper long-dated calls) supports a short-dated hedge and a long-dated asymmetric call exposure.

Key Decisions for Investors

• Tactical short TSLA via a 3–6 month put spread (sell-to-open short-dated call or buy 3–6m put spread with net debit sized to 1–2% portfolio). Rationale: hedge for 15–25% downside from margin compression/cannibalization; capped loss if product is better-than-feared. Target payoff ~3:1 if margins move adverse by 200–400bps.
• Long-dated asymmetric call on TSLA to capture optionality if volume play works: buy Jan-2028 LEAP calls (or 24–36m equivalent). Rationale: limited premium for multi-year upside from global volume and eventual FSD monetization; pair with short-dated puts to reduce net cost.
• Long Chinese supply chain exposure: buy CATL/300750.SZ or BYD (1211.HK) for 12–24 months to capture localization-led margin gains and outsized cell/LFP share. Rationale: suppliers win from China-first strategy; risk is intensified domestic competition and price erosion.
• Pair trade (balanced): short TSLA near-term equity/options (3–6m) vs long Chinese supplier (12m). Rationale: captures asymmetric outcome—near-term margin squeeze for Tesla vs supplier benefit from localization. Size to net market-neutral exposure, monitor headlines for supplier RFPs and tooling orders as entry triggers.